The year 2026 is witnessing the first clinical applications of CAR-T cell therapy for severe, refractory autoimmune kidney disease. By engineering a patient's own T-cells to specifically target the B-cells producing PLA2R antibodies, researchers are achieving complete immunological cures in patients who failed all other nephrotic syndrome therapies. While currently reserved for extreme cases,...
The vibrant and unparalleled venture capital (VC) and mergers and acquisitions (M&A) ecosystem in the United States is the primary financial engine of innovation and a critical catalyst for the Artificial Intelligence Market Trends. The US is home to the world's deepest, most sophisticated, and most risk-tolerant pool of private capital, which has been instrumental in funding the...
Exploring Autonomous Assistance in Simulated Surgical Environments
As we look deeper into the year 2026, the introduction of semi-autonomous features in surgical robots is being carefully modeled in simulation. These systems can handle repetitive tasks like holding a camera or providing suction, allowing the lead surgeon to focus on more complex maneuvers. Simulators are essential for teaching...
"In-Depth Study on Executive Summary Vaping Illness Market Size and Share
CAGR Value
Vaping illness market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.90% in the above mentioned forecast period.
Vaping Illness Market research report contains a key data about the market,...